Probing the size of a hydrophobic binding pocket within the allosteric site of muscarinic acetylcholine M2-receptors

被引:26
作者
Bender, W
Staudt, M
Tränkle, C
Mohr, K
Holzgrabe, U
机构
[1] Univ Wurzburg, Inst Pharm, Dept Pharmaceut Chem, D-97074 Wurzburg, Germany
[2] Univ Bonn, Inst Pharm, Dept Pharmacol & Toxicol, D-53121 Bonn, Germany
关键词
alkane bisammonium compounds; allosteric modulation; M-2 acetylcholine receptors; quantitative structure-activity relationships;
D O I
10.1016/S0024-3205(00)00490-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hexane-bisammonium-type compounds containing lateral phthalimide moieties are known to have a rather high affinity for the allosteric site of muscarinic M-2 receptors. In order to get more insight into the contribution of the lateral substituents for alloster binding affinity, a series of compounds with unilaterally varying imide substituents were synthesized and tested for their ability to retard allosterically the dissociation of [H-3]N-methylscopolamine fi om the receptor protein (control t(1/2) = 2 min; 3 mM MgHCO4, 50 mM Tris, pH 7.3, 37 degrees C). Among the test compounds, the naphthalimide containing agent (half maximum effect at EC50,diss = 60 nM) revealed the highest potency. Apparently, its affinity for the allosteric site in NMS-occupied receptors is 20fold higher compared with the phthalimide containing parent compound W 84. Analysis of quantitative structure-activity relationships yielded a parabolic correlation between the volume of the lateral substituents and the allosteric potency. The maximal volume was determined to be approximately 600 Angstrom(3) suggesting that the allosteric binding site contains a binding pocket of a defined size for the imide moiety.
引用
收藏
页码:1675 / 1682
页数:8
相关论文
共 20 条
[1]   A STABLE AND HIGHLY POTENT HEXAMETHONIUM DERIVATIVE WHICH MODULATES MUSCARINIC RECEPTORS ALLOSTERICALLY IN GUINEA-PIG HEARTS [J].
BEJEUHR, G ;
BLASCHKE, G ;
HOLZGRABE, U ;
MOHR, K ;
SURIG, U ;
TERFLOTH, G .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (02) :108-112
[2]  
BEJEUHR G, 1992, PHARM PHARM LETT, V2, P100
[3]  
BOTERO C, 1994, J MED CHEM, V37, P1439
[4]   Allosteric interactions at muscarinic cholinoceptors [J].
Christopoulos, A ;
Lanzafame, A ;
Mitchelson, F .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (3-4) :185-194
[5]  
Ellis J, 1997, DRUG DEVELOP RES, V40, P193
[6]   Comparison of structurally different allosteric modulators of muscarinic receptors by self-organizing neural networks [J].
Holzgrabe, U ;
Wagener, M ;
Gasteiger, J .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1996, 14 (04) :185-&
[7]   Allosteric modulators of ligand binding to muscarinic acetylcholine receptors [J].
Holzgrabe, U ;
Mohr, K .
DRUG DISCOVERY TODAY, 1998, 3 (05) :214-222
[8]   Conformational analysis, molecular shape comparison, and pharmacophore identification of different allosteric modulators of muscarinic receptors [J].
Holzgrabe, U ;
Hopfinger, AJ .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (05) :1018-1024
[9]   ALLOSTERIC EFFECT ON MUSCARINIC M(2)-RECEPTORS OF DERIVATIVES OF THE ALKANE-BIS-AMMONIUM COMPOUND W84 - COMPARISON WITH BISPYRIDINIUM TYPE ALLOSTERIC MODULATORS [J].
KOSTENIS, E ;
HOLZGRABE, U ;
MOHR, K .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1994, 29 (12) :947-953
[10]   Evidence for a multiple binding mode of bispyridinium-type allosteric modulators of muscarinic receptors [J].
Kostenis, E ;
Cid, HMB ;
Holzgrabe, U ;
Mohr, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 314 (03) :385-392